Inventor · disambiguated record
Uwe Gritzan
Also filed as: GRITZAN UWE
14 granted patents·8 pending applications·37 citations·filing 2008–2024
89Inventor score
Top patents by PatentIndex Score
22 records- 0192US11427640B1CCR8 antibodies for therapeutic applicationsBAYER IP GMBH·Filed 2021·Granted Aug 30, 2022·4 cites·15 claims
- 0289US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 0385US10584167B2Anti-CEACAM6 antibodies and uses thereofBayer Pharma AG·Filed 2016·Granted Mar 10, 2020·4 cites·16 claims
- 0485US8399627B2Antibodies to TNFαVOTSMEIER CHRISTIAN·Filed 2008·Granted Mar 19, 2013·17 cites·12 claims
- 0579US11866495B2Anti-CEACAM6 antibodies and uses thereofDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2020·Granted Jan 9, 2024·1 cites·20 claims
- 0679US2024376218A1Ccr8 antibodies for therapeutic applicationsBAYER AG·Filed 2024·Application pending·0 cites
- 0779US2024400700A1Ccr8 antibodies for therapeutic applicationsBAYER AG·Filed 2024·Application pending·0 cites
- 0875US9593166B2Monoclonal antibodies against antithrombin βBAYER HEALTHCARE LLC·Filed 2014·Granted Mar 14, 2017·2 cites·1 claims
- 0973US11655297B2ILDR2 antagonists and combinations thereofBAYER AG·Filed 2018·Granted May 23, 2023·1 cites·18 claims
- 1072US12065497B2Methods of treatment using CCR8 antibodiesBAYER AG·Filed 2022·Granted Aug 20, 2024·0 cites·17 claims
- 1170US9908942B2Monoclonal antibodies against antithrombin βBAYER HEALTHCARE LLC·Filed 2014·Granted Mar 6, 2018·1 cites·7 claims
- 1268US9534046B2Antibodies to TNFαBAYER IP GMBH·Filed 2015·Granted Jan 3, 2017·1 cites·18 claims
- 1361US11773164B2Anti-CEACAM6 antibodies and uses thereofBayer Pharma AG·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 1457US10144784B2Monoclonal antibodies against antithrombin betaBAYER HEALTHCARE LLC·Filed 2018·Granted Dec 4, 2018·0 cites·18 claims
- 1555US10266583B2Variant factor VIII polypeptides and methods of their production and useBAYER HEALTHCARE LLC·Filed 2018·Granted Apr 23, 2019·0 cites·14 claims
- 1653US9914764B2Variant factor VIII polypeptides and methods of their production and useBAYER HEALTHCARE LLC·Filed 2014·Granted Mar 13, 2018·0 cites·12 claims
- 1749US2022169736A1Combinations of anti-ildr2 antibodies and pd-1 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 1848US2013230886A1Antibodies to TNF AlphaVOTSMEIER CHRISTIAN·Filed 2013·Application pending·0 cites
- 1943US2016237160A1Anti-tweakr antibodies and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2039US2018318438A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-tweakr-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2136US2018185510A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-b7h3-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2234US2012164130A1Modified Factor IX Polypeptides and Uses ThereofBROOKS ALAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Uwe Gritzan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →